Collaboration Anticipated to Improve Medical Suppliers’ Entry to Complete Genomic Testing
DENVER, January 25, 2023–(BUSINESS WIRE)–VieCure immediately introduced a brand new collaboration with Labcorp to supply clinicians better entry to precision oncology resolution help. This strategic collaboration will help patient-specific remedy plans by integrating Labcorp’s precision medication testing options with VieCure’s scientific resolution help instrument, serving to neighborhood most cancers care suppliers advance well being fairness and improve precision diagnostic check utilization for most cancers sufferers, together with these dwelling in rural and distant areas who might lack entry to bigger oncology facilities. Collectively, the 2 corporations shall be positioned to enhance scientific outcomes for sufferers, making a streamlined expertise for biomarker-informed, personalised most cancers care by an built-in clinic-genomic workflow of Labcorp’s precision medication testing options.
This press launch options multimedia. View the total launch right here: https://www.businesswire.com/information/house/20230125005608/en/
Labcorp’s complete portfolio of most cancers diagnostic and next-generation sequencing merchandise shall be absolutely built-in into the VieCure platform, enhancing the scientific workflow expertise for neighborhood oncologists to assist in precision medication choice for oncology sufferers and drive higher outcomes (Photograph: Enterprise Wire)
“Practically 75% of most cancers sufferers in the US are handled locally and personal observe settings,” stated Dr. Fred Ashbury, chief scientific officer at VieCure. “We have now a possibility to assist additional democratize precision oncology and make it simpler for neighborhood oncologists to supply the best take care of the best affected person each time.”
Subsequent-generation sequencing (NGS) has turn out to be foundational for precision oncology, with quickly increasing diagnostic, prognostic, and therapeutic implications, however a there are a variety of challenges for information requirements and interoperability that make it tough for clinicians to successfully handle and keep up-to-date on potential remedies. Labcorp’s complete precision oncology check menu contains centralized options – together with NGS-based assessments spanning strong tumors, hematologic malignancies, and hereditary cancers – and kitted options (by the Feb. 2022 acquisition of Private Genome Diagnostics Inc.), permitting establishments to internalize NGS and supply testing in home and combine complete molecular information into affected person data.
“Labcorp’s management and scale in precision medication diagnostic testing and drug improvement will speed up entry to personalised remedies for most cancers sufferers handled in neighborhood oncology practices,” stated Prasanth Reddy, MD, MPH, FACP, senior vice chairman and world head of oncology at Labcorp. “Labcorp’s complete portfolio of most cancers diagnostic and next-generation sequencing merchandise shall be absolutely built-in into the VieCure platform, enhancing the scientific workflow expertise for neighborhood oncologists to assist in precision medication choice for oncology sufferers and drive higher outcomes.”
About VieCure
VieCure has developed a proprietary synthetic intelligence informatics software program platform at the side of a scientific inference engine and point-of-care resolution help system in oncology. The VieCure™ platform combines the newest in scientific data with affected person information to help clinicians in producing personalised remedy plans and higher managing a affected person’s remedy all through prognosis, most cancers remedy, and ongoing follow-up care. VieCure was launched in 2016 and has contracted with main neighborhood oncology most cancers facilities just like the Heart for Most cancers and Blood Problems (Fort Price, Texas), Alabama Most cancers Care (Tuscaloosa, Alabama), Clermont Oncology (Clermont, Florida), and a number of other others together with the American Oncology Community. The VieCure contracted most cancers middle community now contains greater than 100 areas in the US, the Bahamas, and Antigua. Lively implementation of the VieCure platform is going on in community areas throughout the US. For extra info, please go to VieCure.com and join with VieCure on LinkedIn, Fb, and YouTube.
View supply model on businesswire.com: https://www.businesswire.com/information/house/20230125005608/en/
Contacts
VieCure, Inc.
Hailey Hogue, Coordinator, Advertising and Social Media
hailey.hogue@viecure.com
